Evalution of formulations of anticacer,antivital and antibiotic drugs containing a novel bioavallability enhancer(RLJ:NE:210)
Evaluation of formulations of anticancer antiviral and antibiotic drugs containing a novel bioavailability enhancer RLJ NE 210